Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Menopause Market’s Growth Trajectory From 2025 To 2034?
The size of the menopause market has experienced significant growth in the past few years. It is projected to rise from $17.74 billion in 2024 to $18.78 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors contributing to the growth during the historic period include enhanced longevity, heightened awareness of women’s health, the use of nutritional supplements, improvements in healthcare accessibility, stress and lifestyle management, and advocacy for patients.
The menopause market size is expected to see strong growth in the next few years. It will grow to $24.29 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp
What are the Fundamental Drivers and Innovations Shaping the Menopause Market?
The rising levels of physical inactivity in women are anticipated to bolster the expansion of the menopause market. Physical inactivity, which includes an absence or limited amount of physical movement encompassing all kinds of activities from leisure time mobility to commuting and occupational movements, is escalating among women experiencing menopause. This rise contributes to an increased demand for products and services that cater to menopausal symptoms, health threats, and overall wellness. As an example, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported in June 2024 that 27% of global adults were physically inactive in 2022, and this is forecasted to surge to 35% by 2030. As a result, the growing physical inactivity in women is a key driving force for the menopause market.
How Is the Menopause Market Segmented?
The menopausemarket covered in this report is segmented –
1) By Treatment: Dietary Supplements; Over-The-Counter (OTC) Pharma Products
2) By Route Of Administration: Topical; Oral; Injectables
3) By Distribution Channel: Hospital; Retail; Online Pharmacies
4) By End User: Hospital; Diagnostic Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Dietary Supplements: Herbal Supplements; Vitamins And Minerals; Phytoestrogens; Omega-3 Fatty Acids; Probiotics
2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT); Non-Hormonal OTC Products; Antidepressants for Mood Swings; Sleep Aids; Pain Relievers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13190&type=smp
Which Regions Are Driving the Next Phase of the Menopause Market Growth?
North America was the largest region in the menopause market in 2024. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Trends Are Shaping the Future of the Menopause Market?
Major companies operating in the menopause market are focusing on developing innovative products, such as Your Meno Ease Capsules, to meet the needs of existing consumers better. Your Meno Ease Capsules is a dietary supplement that helps to relieve the symptoms of menopause in women and contains a blend of vitamins, minerals, and other nutrients that are thought to be beneficial for menopausal women. For instance, in October 2022, PharmaLinea Ltd., a Slovenia-based manufacturer of menopausal dietary supplements, launched Your Meno Ease Capsules. These revolutionary capsules are innovative with unique components and clinically validated functions ranging from general menopausal symptom alleviation to extra advantages in state of mind, mental processes, distress, cardiovascular, and bone wellness. PharmaLinea’s product is a single capsule comprising 75 mg of Qratol and 40 mg of Qsoy. It also has 1.6 mg of vitamin B6. Qsol is a soy component that has been found to reduce menopausal symptoms, while Qratol is a resveratrol substance that offers several health benefits.
View the full report here:
https://www.thebusinessresearchcompany.com/report/menopause-global-market-report
How Is the Menopause Market Defined and What Are Its Core Parameters?
Menopause is a natural biological process that marks the end of a woman’s menstrual cycles and reproductive years, diagnosed after a woman has gone 12 consecutive months without a menstrual period. It is often associated with various physical and hormonal changes signaling the end of the reproductive years when the ovaries stop releasing eggs and the hormones progesterone and estrogen become less abundant.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13190
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model